Daniel P Hurkmans
10PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Jun 05, 2021
Prospective real-world study on the pharmacokinetics of pembrolizumab in patients with solid tumors.Daan P Hurkmans, Sebastiaan D T Sassen, Karlijn de Joode
|Jan 11, 2021
Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer.Daan P Hurkmans, Els M E Verdegaal, Sabrina A Hogan
|Oct 23, 2020
Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma.Daan P Hurkmans, Christina Jensen, Stijn L W Koolen
|Jul 08, 2020
A Serum Protein Classifier Identifying Patients with Advanced Non-Small Cell Lung Cancer Who Derive Clinical Benefit from Treatment with Immune Checkpoint Inhibitors.Mirte Muller, Karlijn Hummelink, Daan P Hurkmans
|May 29, 2020
Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancer.Daan P Hurkmans, Edwin A Basak, Nina Schepers
Pageof 2
Frequent Collaborators
2 joint publications
Reno Debets
1 joint publications
Kim Monkhorst
1 joint publications
Christina Jensen
1 joint publications
Els M E Verdegaal
1 joint publications
Sabrina A Hogan
1 joint publications
Herbert M Pinedo
1 joint publications
Mitchell P Levesque
1 joint publications
Sjoerd H van der Burg
1 joint publications
Karlijn de Joode
1 joint publications
Ron H J Mathijssen
